Fuan Pharmaceutical Group Co Tangible Net Worth Ratio
Fuan Pharmaceutical Group Co tangible net worth ratio. Fuan Pharmaceutical Group Co (300194) has a Tangible Net Worth Ratio of 87.0% as of March 2026. This metric is calculated by deducting intangible assets (CN¥573.77 Million) from net assets (CN¥4.43 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Fuan Pharmaceutical Group Co strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Fuan Pharmaceutical Group Co (2007–2025)
Tangible net worth ratio of Fuan Pharmaceutical Group Co from 2007 to 2025. This chart shows how Fuan Pharmaceutical Group Co's Tangible Net Worth Ratio has changed across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 87.0%, reflecting net assets of CN¥4.43 Billion with intangible assets of CN¥573.77 Million CNY. See 300194 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Fuan Pharmaceutical Group Co Tangible Net Worth Ratio by Year (2007–2025)
Fuan Pharmaceutical Group Co tangible net worth ratio by year from 2007 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Fuan Pharmaceutical Group Co from 2007 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Fuan Pharmaceutical Group Co market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.8% | CN¥4.37 Billion | CN¥574.87 Million | CN¥5.76 Billion | ▼ -0.8 pp |
| 2024 | 87.6% | CN¥4.40 Billion | CN¥544.81 Million | CN¥5.98 Billion | ▲ +0.6 pp |
| 2023 | 87.1% | CN¥4.15 Billion | CN¥537.25 Million | CN¥5.98 Billion | ▲ +1.1 pp |
| 2022 | 85.9% | CN¥3.95 Billion | CN¥554.89 Million | CN¥5.88 Billion | ▲ +0.0 pp |
| 2021 | 85.9% | CN¥3.87 Billion | CN¥545.17 Million | CN¥5.71 Billion | ▲ +11.1 pp |
| 2020 | 74.8% | CN¥4.56 Billion | CN¥1.15 Billion | CN¥5.97 Billion | ▼ -13.5 pp |
| 2019 | 88.3% | CN¥3.99 Billion | CN¥465.67 Million | CN¥4.74 Billion | ▼ -1.5 pp |
| 2018 | 89.8% | CN¥3.69 Billion | CN¥376.26 Million | CN¥4.29 Billion | ▼ -2.1 pp |
| 2017 | 91.9% | CN¥4.17 Billion | CN¥338.71 Million | CN¥4.69 Billion | ▲ +1.0 pp |
| 2016 | 90.9% | CN¥3.96 Billion | CN¥360.68 Million | CN¥4.40 Billion | ▲ +3.8 pp |
| 2015 | 87.1% | CN¥2.14 Billion | CN¥275.46 Million | CN¥2.48 Billion | ▼ -5.8 pp |
| 2014 | 93.0% | CN¥1.71 Billion | CN¥120.30 Million | CN¥1.83 Billion | ▼ -1.1 pp |
| 2013 | 94.1% | CN¥1.72 Billion | CN¥102.45 Million | CN¥1.86 Billion | ▼ -0.6 pp |
| 2012 | 94.7% | CN¥1.72 Billion | CN¥91.23 Million | CN¥1.80 Billion | ▼ -0.3 pp |
| 2011 | 95.0% | CN¥1.69 Billion | CN¥85.09 Million | CN¥1.82 Billion | ▲ +1.5 pp |
| 2010 | 93.4% | CN¥281.05 Million | CN¥18.43 Million | CN¥346.14 Million | ▲ +4.3 pp |
| 2009 | 89.1% | CN¥163.31 Million | CN¥17.72 Million | CN¥273.62 Million | ▼ -1.6 pp |
| 2008 | 90.7% | CN¥110.76 Million | CN¥10.27 Million | CN¥202.59 Million | ▲ +72.0 pp |
| 2007 | 18.8% | CN¥8.31 Million | CN¥6.75 Million | CN¥80.89 Million | — |